BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20260422T170942Z
UID:https://www.ie-freiburg.mpg.de/events/39157/4768318
DTSTART:20241002T110000Z
DTEND:20241002T120000Z
CLASS:PUBLIC
CREATED:20240910T110245Z
DESCRIPTION:Dr. Hannah Uckelmann is Max-Eder junior research group leader a
 t University Hospital Goethe Universität Frankfurt\, Germany. Her lab foc
 uses on studying the epigenetic regulation of self-renewal programs during
  cancer development and the discovery of new therapeutics. Hannah discover
 ed an unexpected role of mutant NPM1 on chromatin representing the molecul
 ar basis for the effectiveness of targeted epigenetic therapies in NPM1 mu
 tant AML. NPM1c cooperates with other chromatin factors to change the chro
 matin landscape and enhance transcriptional output at its target sites. Sh
 e and her team continued investigating NPM1c-driven leukemogenesis with fo
 cus on novel therapeutic therapies in NPM1 mutant AML.\nSpeaker: Hannah Uc
 kelmann
LAST-MODIFIED:20240916T131729Z
LOCATION:MPI-IE\, Room: Main Lecture Hall
ORGANIZER;CN=Nicola Iovino:mailto:
SUMMARY:Max Planck Seminar: Max Planck Seminar: Hannah Uckelmann - Targetin
 g chromatin regulators during leukemia development
URL;VALUE=URI:https://www.ie-freiburg.mpg.de/events/39157/4768318
END:VEVENT
END:VCALENDAR